title: Targeted Myostatin Gene Editing in Multiple Mammalian Species Directed by a Single Pair of TALE Nucleases.
abstract: Myostatin (MSTN) is a negative regulator of skeletal muscle mass. Strategies to block myostatin signaling pathway have been extensively pursued to increase muscle mass in various disease settings including muscular dystrophy. Here, we report a new class of reagents based on transcription activator-like effector nucleases (TALENs) to disrupt myostatin expression at the genome level. We designed a pair of MSTN TALENs to target a highly conserved sequence in the coding region of the myostatin gene. We demonstrate that codelivery of these MSTN TALENs induce highly specific and efficient gene disruption in a variety of human, cattle, and mouse cells. Based upon sequence analysis, this pair of TALENs is expected to be functional in many other mammalian species. Moreover, we demonstrate that these MSTN TALENs can facilitate targeted integration of a mCherry expression cassette or a larger muscular dystrophy gene (dysferlin) expression cassette into the MSTN locus in mouse or human cells. Therefore, targeted editing of the myostatin gene using our highly specific and efficient TALEN pair would facilitate cell engineering, allowing potential use in translational research for cell-based therapy.Molecular Therapy-Nucleic Acids (2013) 2, e112; doi:10.1038/mtna.2013.39; published online 30 July 2013.
authors.affiliation: Department of Cell and Molecular Physiology, Loyola University Chicago Health Science Division, Maywood, Illinois.
authors.forename: Li
authors.initials: L
authors.lastname: Xu
authors.forename: Piming
authors.initials: P
authors.lastname: Zhao
authors.forename: Andrew
authors.initials: A
authors.lastname: Mariano
authors.forename: Renzhi
authors.initials: R
authors.lastname: Han
references.citation: J Biomed Biotechnol. 2011;2011:235216
references.pmid: 21941430
references.citation: Nature. 2011 Jun 26;475(7355):217-21
references.pmid: 21706032
references.citation: Expert Opin Investig Drugs. 2005 Sep;14(9):1099-106
references.pmid: 16144494
references.citation: J Mol Biol. 2010 Jul 2;400(1):96-107
references.pmid: 20447404
references.citation: Nature. 2002 Nov 28;420(6914):418-21
references.pmid: 12459784
references.citation: Skelet Muscle. 2011 Jan 24;1(1):2
references.pmid: 21798080
references.citation: Nucleic Acids Res. 2012 Jul;40(Web Server issue):W117-22
references.pmid: 22693217
references.citation: Science. 2009 Dec 11;326(5959):1501
references.pmid: 19933106
references.citation: Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1156-60
references.pmid: 8577732
references.citation: Biochem Biophys Res Commun. 2003 Jan 24;300(4):965-71
references.pmid: 12559968
references.citation: Nucleic Acids Res. 2011 Aug;39(14):6315-25
references.pmid: 21459844
references.citation: Nucleic Acids Res. 2010 Dec;38(22):8269-76
references.pmid: 20716517
references.citation: PLoS Genet. 2007 May 25;3(5):e79
references.pmid: 17530926
references.citation: Nucleic Acids Res. 2011 Nov;39(21):9283-93
references.pmid: 21813459
references.citation: Science. 2009 Dec 11;326(5959):1509-12
references.pmid: 19933107
references.citation: Nat Biotechnol. 2004 May;22(5):589-94
references.pmid: 15064769
references.citation: Nature. 1997 May 1;387(6628):83-90
references.pmid: 9139826
references.citation: Nat Genet. 1997 Sep;17(1):71-4
references.pmid: 9288100
references.citation: Nat Biotechnol. 2005 Aug;23(8):967-73
references.pmid: 16082368
references.citation: Nucleic Acids Res. 1999 Jan 15;27(2):674-81
references.pmid: 9862996
references.citation: Proc Natl Acad Sci U S A. 2012 Oct 23;109(43):17382-7
references.pmid: 23027955
references.citation: Nature. 2012 Nov 1;491(7422):114-8
references.pmid: 23000899
references.citation: Nat Biotechnol. 2007 Jul;25(7):778-85
references.pmid: 17603475
references.citation: Nucleic Acids Res. 2011 Jul;39(12):e82
references.pmid: 21493687
references.citation: Nat Biotechnol. 2008 Jul;26(7):808-16
references.pmid: 18587387
references.citation: FASEB J. 2008 Feb;22(2):477-87
references.pmid: 17893249
references.citation: Nat Methods. 2011 Jan;8(1):74-9
references.pmid: 21131970
references.citation: Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12457-61
references.pmid: 9356471
references.citation: Am J Physiol Endocrinol Metab. 2003 Aug;285(2):E363-71
references.pmid: 12721153
references.citation: J Cell Biochem. 2008 Oct 1;105(2):353-64
references.pmid: 18615595
references.citation: Curr Opin Clin Nutr Metab Care. 2004 May;7(3):259-63
references.pmid: 15075916
references.citation: Curr Aging Sci. 2010 Jul;3(2):90-101
references.pmid: 20158492
references.citation: Nat Biotechnol. 2007 Jul;25(7):786-93
references.pmid: 17603476
references.citation: Nucleic Acids Res. 2000 Sep 1;28(17):3361-9
references.pmid: 10954606
references.citation: Am J Pathol. 2006 Jun;168(6):1975-85
references.pmid: 16723712
references.citation: Genome Res. 1997 Sep;7(9):910-6
references.pmid: 9314496
references.citation: J Appl Physiol (1985). 2011 Apr;110(4):1065-72
references.pmid: 21270350
references.citation: Nat Genet. 2006 Jul;38(7):813-8
references.pmid: 16751773
references.citation: Nat Methods. 2010 Feb;7(2):91; author reply 91-2
references.pmid: 20111032
references.citation: Nat Biotechnol. 2011 Jul 07;29(8):731-4
references.pmid: 21738127
references.citation: Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3055-60
references.pmid: 17360608
references.citation: J Mol Biol. 2011 Jan 21;405(3):630-41
references.pmid: 21094162
references.citation: N Engl J Med. 2004 Jun 24;350(26):2682-8
references.pmid: 15215484